BioCellgraft - BioCellgraft specializes in regenerative health therapies specifically designed to enhance soft and hard tissue regeneration within the oral cavity. Our flagship product, OraFyl, is a highly purified biological matrix derived from the chorionic portion of the human placenta (HPCTM - Human Placenta Connective Tissue Matrix). It consists of native collagen and elastin presented in their most purified molecular scaffold form.

BioCellgraft specializes in regenerative health therapies specifically designed to enhance soft and hard tissue regeneration within the oral cavity. Our flagship product, OraFyl, is a highly purified biological matrix derived from the chorionic portion of the human placenta (HPCTM – Human Placenta Connective Tissue Matrix). It consists of native collagen and elastin presented in their most purified molecular scaffold form.

OraFyl uniquely presents as a flowable gel, suitable for direct injection into tissues or mixing with bone or soft tissue substitutes, providing a versatile “all-in-one” therapeutic approach.

Our products uniquely address a critical gap in current oral healthcare by providing unparalleled support for tissue enhancement. BioCellgraft’s solutions offer superior treatment outcomes for patients with existing oral health concerns and proactively help prevent further oral and overall health issues. By significantly strengthening oral cavity health, our therapies enable clinicians to achieve enhanced clinical outcomes, promoting better overall patient wellness.